Ever growing Plavix and Lipitor sales encountered challenges.

Published: 2007-08-14 07:00:00

Updated: 2007-08-14 07:00:00

Plavix, an anti-arteriosclerosis by Sanofi-Aventis and Lipitor, an anti-cholesterol drug by BMS Korea and Pfizer Korea, have enjoyed with ever growing sales in the market since long time but recently encountered with challenges by a market entry of those generic drugs including Dong-A's Plavitol,...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK